Therapy Areas

Renal
Syner-Med first developed and introduced IV Iron Sucrose to Renal Units across the UK in 1994. Since this time, Syner-Med has successfully developed a strong presence and relationship within the Renal arena.
Urology
Millions of people each year find themselves compromised by Urological Disorders. Syner-Med is committed to the development of therapies and treatments in the field of Urology.
Oncology
Building strong relationships with with healthcare professionals in oncology. Syner-Med provides UK Oncology Units with Catheter Management products to improve Clinical Outcomes and enhance patient wellbeing.
Immunology
Syner-Med are developing novel products in the antibody therapeutic field, with the development of immunostimulators in the areas of Recurrent Urinary Tract Infections (RUTIs) and Upper Respiratory Tract Infections (URTI).
Gynaecology
Our Women’s Health products offer clinicians and patients effective treatments.
Reporting of side effects. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine. Adverse events should also be reported to Syner-Med (Pharmaceutical Products) Limited. Tel. +44 020 8655 6380

Leave us a message

CONTACT US

International headquarters
Syner-Med (Pharmaceutical Products) Ltd.
Syner-Med House
120 High Street
Purley, Surrey
CR8 2AD, United Kingdom

Tel: +44 (0)20 8655 6380
E: mail@syner-med.com